Our previous study found apelin-13 improves cognitive function in Alzheimer’s disease (AD) rats by inhibiting neuroinflammation through upregulation of BDNF/TrkB signaling pathway. Here, APLN is linked to early-onset autosomal dominant Alzheimer disease.